PROKIDNEY CORP.
PROK · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Pereira Brian JG: Form 4
Insider disclosure · Filed · Report period 18 Aug 2026
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001850270 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PROK on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 2000 Frontis Plaza Blvd., Suite 250, Winston Salem, NC, 27103
- Incorporated in
- Cayman Islands
- Fiscal year end
- 31 December
- Former names on EDGAR
- Social Capital Suvretta Holdings Corp. III (to 11 Jul 2022)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields